Skip to content

Clinical Evaluation of Vatha Karappan (Ecezma)

A Clinical Evaluation of CHARANAI KUDINEER (Internal medicine) BOOTHAKARAPPANPATTAI ENNAI (External medicine) siddha drug for VATHA KARAPPAN in children on open clinical study - Ecezma

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/06/006983
Enrollment
40
Registered
2016-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with symptoms of Skin rashes or bumpy rashes or blisters,Papules, vesicles, pustules,

Interventions

Intervention1: CHARANAI KUDINEER (Internal medicine) & BOOTHAKARAPPANPATTAI ENNAI (External medicine): CHARANAI KUDINEER is a poly herbal formulation 20 ml (b.d)duration of 14 days Control Interventi

Sponsors

National institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria 1. Age 7 to 12 years 2.Skin rashes or bumpy rashes or blisters, Papules, vesicles, pustules, Ulcer formation with oozing, Swelling, Pain, Fever 3. Patients willing to give specimen of blood for investigation when required. 4. Patients willing to be admitted in the hospital or willing to attend OPD once in 7 days for 14 days

Exclusion criteria

Exclusion criteria: Scabies Photo dermatitis Patient with any other serious illness which needs discontinuity of trial drug Seborrhoeic dermatitis Nummular dermatitis Fungal or parasitic skin infections

Design outcomes

Primary

MeasureTime frame
Good-reduced all clinical symptoms Moderate-reduced some clinical symptoms Poor-No improvement or change in clinical symptomsTimepoint: With in 14 days

Secondary

MeasureTime frame
It is mainly assessed by therapeutic efficacy of the trial drugsTimepoint: 1-3 months

Countries

India

Contacts

Public ContactDrMMeenakshi Sundaram

National Institute of Siddha

mmssiddha@gmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026